Metabolism


Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
B5729 GPP 78 hydrochlorideSummary: NAMPT inhibitor -
B5750 ML 281Target: STKSummary: serine/threonine kinase STK33 inhibitor -
B5754 ML 298 hydrochlorideSummary: phospholipase D2 (PLD2) inhibitor -
C7063 2,6-Dihydroxyanthraquinone -
C7113 3-Methylpyrazole -
C7156 10-Undecen-1-ol -
C7196 Chelidamic acid -
B8796 RS 09 TFA -
B8902 TXNIP-IN-1 -
B8905 Adenosine 5'-monophosphate disodium

